‘Not unnoticed’: Sunak issues letter of support to community pharmacy

Prime Minister Rishi Sunak has written to the Sigma Pharmaceuticals conference to express his “personal gratitude” to the sector.

“Your incredible work does not go unnoticed”, the Prime Minister said

Prime Minister Rishi Sunak has expressed his “personal gratitude” to the community pharmacy sector, in a letter of “encouragement and support” addressed to Sigma Pharmaceutical’s 2023 UK community pharmacy conference.

Lord Dolar Popat, who opened the Sigma event yesterday (November 5), read out the letter to delegates – stressing that the Prime Minister is the “son of a pharmacist”.

Read more: In full: Rishi Sunak's letter to the sector

Mr Sunak wrote that the government “very much appreciates” the community pharmacy sector’s “hard work”.

He said that community pharmacies play an “important role in maintaining and looking after local communities”, adding that this “incredible work” was not “unnoticed”.

He ended his letter by expressing his hope that the delegates felt “recognised” for their work.

Pharmacy First will prove “value and trust”

Mr Sunak’s letter also said that the government wants to “enable” the sector to “do more to support the NHS”.

The Prime Minister said that the upcoming Pharmacy First service, announced in May, would be “an important addition” to the work of pharmacies, with pharmacists providing initial assessments of patients and “some options for treatment” without a patient requiring a GP appointment.

Read more: Pharmacy First negotiations ‘concluded’, CPE chief announces

He added that additional services provided by pharmacists under the deal would prove “how valuable and trusted” community pharmacy is within communities.

It comes as C+D today (November 6) reported that the negotiations for the Pharmacy First deal had been concluded with the details to be announced “very shortly”, according to Community Pharmacy England (CPE) chief executive Janet Morrison.

Sign in or register for free

James Stent

Read more by James Stent

James Stent joined C+D as a digital reporter in May 2023 from the South African human rights news agency GroundUp, where he was senior reporter and consultant editor.

Latest from News

Sebco coal tar scalp ointment appointed by DHSC to support current shortages

 • comment1

Due to shortages in coal tar scalp ointment, the DHSC has asked the manufacturer of an equivalent product - Sebco - to provide increased stock levels to support patients during this time.

Pharmacies to boost naloxone stock amid ‘sudden’ overdose spike

 
• By 
 • comment0

Pharmacies in Scotland have been asked to ensure they have the “appropriate stock” of naloxone – a medicine used to reverse the effects of an opiate overdose – following an “increase in sudden collapse” due to overdoses.

Cuts and commissioning: What does NHSE’s axing mean for ICBs?

 
• By 
 • comment5

As the dust settles on the announcement that NHS England (NHSE) is set for the scrapheap, questions on what a 50% headcount cut means for local commissioners remain…

More from Politics

breaking news

IN FULL: Starmer reveals plans to abolish NHSE

 
• By 
 • comment

Prime Minister Keir Starmer has announced that NHS England will be abolished to bring the management of the NHS “back into democratic control”.

Royal college row: RPS hits back at critics as CPhOs say ‘vote yes’

  • comment

The Royal Pharmaceutical Society (RPS) has responded to criticisms of its plans to register as a charity and gain royal college status, stressing that it followed a “democratic process”.